Analysis | Metabolite Name | Measured Value | Units | Treatment | Timepoint |
---|---|---|---|---|---|
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 0.948 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 2.12 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 2.12 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 2.16 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 2.29 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 2.32 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 3.28 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 3.53 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 3.6 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 3.66 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 3.75 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 3.98 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 4.18 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 4.51 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 4.66 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 4.75 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 4.78 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 5.04 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 5.39 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 5.45 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 5.7 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 5.74 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 5.86 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 6.02 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 6.07 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 6.07 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 6.51 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 6.67 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 7.15 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 7.28 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 7.5 | nM | Early ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 7.72 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 7.74 | nM | Late ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 8.15 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 8.95 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.28 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.32 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.45 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.54 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.55 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.57 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 9.59 | nM | Late ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.1 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.1 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.375 | nM | Early ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.4 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.5 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.6 | nM | Early ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 10.6 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 11 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 11.6 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 11.6 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 11.8 | nM | Late ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 11.9 | nM | GLP1/Late GTT | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 12.5 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 13.2 | nM | Late ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 13.5 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 13.5 | nM | Late ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 13.8 | nM | Early ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 15.1 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 15.2 | nM | Early ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 15.4 | nM | Early ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 15.4 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 15.4 | nM | Late ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 16 | nM | Early ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 16.5 | nM | Early ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 17.1 | nM | Late ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 17.4 | nM | Late ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 18.6 | nM | GLP1/Late GTT | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 18.8 | nM | Late ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 20.6 | nM | Late ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 20.7 | nM | Early ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 21.4 | nM | Early ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 21.4 | nM | Early ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 21.9 | nM | Late ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 22.5 | nM | Early ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 23 | nM | Early ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 24.9 | nM | Early ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 26.5 | nM | GLP1/Late GTT | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 27.9 | nM | Early ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 28.5 | nM | Early ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 28.7 | nM | Early ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 28.7 | nM | Late ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 32.1 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 33 | nM | Early ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 33 | nM | Late ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 35.9 | nM | Late ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 37.2 | nM | Early ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 38.6 | nM | Late ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 39.6 | nM | Late ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 39.7 | nM | Early ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 40.2 | nM | Early ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 41.7 | nM | GLP1/Late GTT | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 42.4 | nM | Late ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 44.1 | nM | Late ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 44.2 | nM | Early ITT Infusion Study | 10 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 49.6 | nM | Early ITT Infusion Study | 60 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 52 | nM | Early ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 56.4 | nM | Late ITT Infusion Study | 30 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 69.3 | nM | GLP1/Late GTT | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 80 | nM | Late ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 92.8 | nM | Late ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 128 | nM | Late ITT Infusion Study | 0 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 134 | nM | Late ITT Infusion Study | 120 mins |
LCMS Positive ion mode | 2-Arachidonoyl Glycerol | 164 | nM | Late ITT Infusion Study | 120 mins |